Adverse Effects of Esketamine for the Treatment of Major Depression Disorder: Findings from Randomized Controlled Trials

Esketamine is a promising drug which can induce antidepressant effects in Major Depression Disorder (MDD). Several randomized controlled trials (RCTs) have been implemented to assess the efficacy and safety of esketamine for the treatment of MDD. Therefore, we carried out a meta-analysis to assess a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Siyuan, Wang, Jiahe, Li, Xiang, Wang, Tianyi, Xu, Zhongmou, Xu, Xiang, Zhou, Xinmin, Chen, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993781/
https://www.ncbi.nlm.nih.gov/pubmed/33411126
http://dx.doi.org/10.1007/s11126-020-09871-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993781/
https://www.ncbi.nlm.nih.gov/pubmed/33411126
http://dx.doi.org/10.1007/s11126-020-09871-x

Ejemplares similares